
<!DOCTYPE html>
<html lang="en-US" class=" js">
<head>
<!-- Google tag (gtag.js) -->
<script async src="https://www.googletagmanager.com/gtag/js?id=G-1CD9F90731"></script>
<script>
  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag('js', new Date());

  gtag('config', 'G-1CD9F90731');
</script>


<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-8495225890363177"
     crossorigin="anonymous"></script>
     
 

<link rel="stylesheet" href="https://education-academia.github.io/css/bootstrap.min.css">
<link rel="stylesheet" href="https://education-academia.github.io/css/style.css">
<link rel="stylesheet" href="https://education-academia.github.io/css/custom.css">
<link rel="icon" href="https://education-academia.github.io/images/favicon.png" type="image/x-icon">
<link href="https://cdn.rawgit.com/westonganger/bootstrap-directional-buttons/master/dist/bootstrap-directional-buttons.css" rel="stylesheet" type="text/css">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Which is the first country to approve Mercks Oral Covid Pill?
</title>
<meta name="description" content="Molnupiravir was developed at Emory University by its drug innovation company, Drug Innovation Ventures at Emory (DRIVE).The vaccine is administered in two doses that are given three weeks apart. In December 2020, the UK became the first country in the world to approve this vaccine and began rolling out an initial 800, 000 doses at the start of the month, and is now in use worldwide.Molnupiravir received its first approval on 4 November 2021 in the UK for the treatment of mild to moderate COVID-19 in adults with a positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnostic test and who have at least one risk factor for developing severe illness.Approved Drugs Olumiant (baricitinib) is approved for the treatment of COVID-19 in hospitalized adults requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).">
<meta name='robots' content='index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1'>
<meta name="keywords" content=" Which country made Molnupiravir?, Which country was the first to approve COVID vaccine?, What is the approval status of Molnupiravir?, What drug is FDA approved for Covid? ">
</head>
<body data-rsssl="1" class="page-template-default custom-background custom-background-white custom-font-enabled single-author" style="padding: 0px 0px 154px;">
<div id="page" class="site" style="height: auto !important;">
<header id="masthead" class="site-header" role="banner">
<div class="io-title-description">
<a href="https://education-academia.github.io" title="Change your future" rel="home">EDUCATION FOR ALL
</a>
<br>
<a class="site-description">The MCQ hub
</a>
</div>
<nav id="site-navigation" class="themonic-nav" role="navigation">
<a class="assistive-text" href="#main" title="Skip to content">Skip to content
</a>
<ul id="menu-top" class="nav-menu">
<li id="menu-item-695195" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-695195">
<a href="https://education-academia.github.io/">Home
</a>
</li>
</ul>
<select class="selectnav" id="selectnav1">
<option value="">Menu
</option>
<option value="https://education-academia.github.io">HOME
</option>
</select>
</nav>
<!-- #site-navigation -->
<div class="clear">
</div>
</header>
<!-- #masthead -->
<div id="main" class="wrapper">
<div id="primary" class="site-content">
<div id="content" role="main">
<article id="post-1014223" class="post-1014223 page type-page status-publish hentry">
<header class="entry-header">
<h1 class="entry-title"> CURRENT AFFAIRS
</h1>
</header>
<div class="entry-content">
<div class="f-l">
<a href="https://education-academia.github.io/current-affairs/2021/what-was-indias-rank-on-the-2021-global-hunger-index.html" class="btn btn-info btn-arrow-left" role="button" aria-pressed="true">Previous
</a>
</div>
<div class="f-r">
<a href="https://education-academia.github.io/current-affairs/2021/when-is-pm-narendra-modi-scheduled-to-address-the-national-summit-on-agro-and-food-processing.html" class="btn btn-info btn-arrow-right" role="button" aria-pressed="true">Next
</a>
</div>
<div style="text-align:center">
<h2>2021 
</h2>
<h3>
</h3>
<p style="text-align: center;">
<a href="https://drive.google.com/drive/folders/1JxfIMvv4AW-4Jl_pC6NHChgZJETuMZiE?usp=share_link" target="_blank" rel="noopener">
<span style="color: #008000;">
<strong>DOWNLOAD FREE PDF BOOK (USEFUL FOR TEACHERS/INSTRUCTORS/COACHING INSTITUTES)
</strong>
</span>
<span style="color: #ff0000;">
<img src="https://education-academia.github.io/download.gif">
</span>
</a>
</p>
</div>
<strong> Which is the first country to approve Merckâ€™s Oral Covid Pill? 
</strong>
<p>(A) India 
</p>
<p>(B) USA 
</p>
<p>(C) ** UK 
</p>
<p>(D) China 
</p>
<p>
<div style ="text-align:center">
<h3>EXPLANATIONS BELOW
</h3>
</div>
<p>
<strong>Concept note-1:
</strong>-Molnupiravir was developed at Emory University by its drug innovation company, Drug Innovation Ventures at Emory (DRIVE).
</p>
<p>
<strong>Concept note-2:
</strong>-The vaccine is administered in two doses that are given three weeks apart. In December 2020, the UK became the first country in the world to approve this vaccine and began rolling out an initial 800, 000 doses at the start of the month, and is now in use worldwide.
</p>
<p>
<strong>Concept note-3:
</strong>-Molnupiravir received its first approval on 4 November 2021 in the UK for the treatment of mild to moderate COVID-19 in adults with a positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnostic test and who have at least one risk factor for developing severe illness.
</p>
<p>
<strong>Concept note-4:
</strong>-Approved Drugs Olumiant (baricitinib) is approved for the treatment of COVID-19 in hospitalized adults requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO). 
<div class="f-l">
<a href="https://education-academia.github.io/current-affairs/2021/what-was-indias-rank-on-the-2021-global-hunger-index.html" class="btn btn-info btn-arrow-left" role="button" aria-pressed="true">Previous
</a>
</div>
<div class="f-r">
<a href="https://education-academia.github.io/current-affairs/2021/when-is-pm-narendra-modi-scheduled-to-address-the-national-summit-on-agro-and-food-processing.html" class="btn btn-info btn-arrow-right" role="button" aria-pressed="true">Next
</a>
</div>
<p style="text-align: center;">
<a href="https://play.google.com/store/books/author?id=Narayan+Changder" target="_blank" rel="noopener">
<span style="color: #008000;">
<strong>BUY E-BOOK WITH ANSWER KEYS GIVEN AT THE END OF EVERY PAGE
</strong>
</span>
<span style="color: #ff0000;">
<img src="https://education-academia.github.io/buynow.webp">
</span>
</a>
</p>
</div>
<!-- .entry-content -->
<footer class="entry-meta">
</footer>
<!-- .entry-meta -->
</article>
<!-- #post -->
<div id="comments" class="comments-area">
</div>
<!-- #comments .comments-area -->
</div>
<!-- #content -->
</div>
<!-- #primary -->
<div id="secondary" class="widget-area" role="complementary">
<aside id="search-3" class="widget widget_search">
<ul>
<li>
<a href="https://education-academia.github.io/current-affairs/2016/1.html">
<strong>CURRENT AFFAIRS-2016
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2017/1.html">
<strong>CURRENT AFFAIRS-2017 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2018/1.html">
<strong>CURRENT AFFAIRS-2018 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2019/1.html">
<strong>CURRENT AFFAIRS-2019 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2020/1.html">
<strong>CURRENT AFFAIRS-2020 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2021/1.html">
<strong>CURRENT AFFAIRS-2021 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2022/1.html">
<strong>CURRENT AFFAIRS-2022 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2023/1.html">
<strong>CURRENT AFFAIRS-2023 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2024/1.html">
<strong>CURRENT AFFAIRS-2024 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2025/1.html">
<strong>CURRENT AFFAIRS-2025
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2026/1.html">
<strong>CURRENT AFFAIRS-2026
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2027/1.html">
<strong>CURRENT AFFAIRS-2027
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2028/1.html">
<strong>CURRENT AFFAIRS-2028 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2029/1.html">
<strong>CURRENT AFFAIRS-2029 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2030/1.html">
<strong>CURRENT AFFAIRS-2030 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/miscellaneous/1.html">
<strong>CURRENT AFFAIRS-MISCELLANEOUS 
</strong>
</a>
</li>
</ul>
</aside>
</div>
<!-- #secondary -->
</div>
<!-- #main .wrapper -->
<footer id="colophon" role="contentinfo">
<div class="site-info">
<div class="footercopy">
</div>
<div class="footercredit">
</div>
<div class="clear">
</div>
</div>
<!-- .site-info -->
</footer>
<!-- #colophon -->
<div class="site-wordpress">
</div>
<!-- .site-info -->
<div class="clear">
</div>
</div>
<!-- #page -->
<script src="https://education-academia.github.io/js/jquery.min.js">
</script>
<script src="https://education-academia.github.io/js/bootstrap.min.js">
</script>
</body>
</html>